	Editorial Comment to Comorbidities in Japanese testicular cancer survivors: A multi-institutional, cross-sectional study. Int J Urol Nakamura Y, Mitsunari K, Imamura R. PMID: 39568289 [PubMed - as supplied by publisher]
	Correlation of Cytokine Profiles with Prostate-Specific Antigen and Disease Grade in Prostate Cancer. Med Sci Monit Basic Res Suli, Marijanovi, Kraljevi, , Kelava T, Mikuli, . PMID: 39568188 [PubMed - indexed for MEDLINE]
	Nomogram for predicting all-cause mortality and cancer-specific mortality after TURBT for non-muscle-invasive bladder cancer. Sci Rep Luo Y, Wei S, Yang J, Tan Z. PMID: 39567720 [PubMed - indexed for MEDLINE]
	Metastasis development in non-muscle-invasive bladder cancer. Nat Rev Urol Leyderman M, Chandrasekar T, Grivas P, Li R, Bhat S, Basnet A, Shapiro O, Jacob J, Daneshvar MA, Kord E, Bratslavsky G, Goldberg H. PMID: 39567681 [PubMed - as supplied by publisher]
	Bladder cancer detection in urine by novel methylation markers. Sci Rep Beijert IJ, Wever BMM, Hentschel AE, van den Burgt Y, Kauer PC, Lissenberg-Witte BI, van Moorselaar RJA, Steenbergen RDM, Nieuwenhuijzen JA. PMID: 39567591 [PubMed - indexed for MEDLINE]
	Quantification of normal bone and osseous metastases in castration-resistant prostate cancer using SPECT/CT with xSPECT Quant: prospective imaging sub-study of a phase 2 clinical trial investigating the combination of pembrolizumab plus radium-223 compared to radium-223 alone. Radiol Med Robertson MS, Wang Y, Cheng S, Park H, Glomski S, Harshman LC, Pace A, Kilar J, Flynn M, Gilbert L, Choudhury AD, Jacene H. PMID: 39565570 [PubMed - as supplied by publisher]
	Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial. Qual Life Res Nabid A, Carrier N, Martin AG, Bahary JP, Vavassis P, Vass S, Bahoric B, Archambault R, Vincent F, Bettahar R, Souhami L. PMID: 39565556 [PubMed - as supplied by publisher]
	Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis. Curr Oncol Rep Frazer R, Arranz JÁ, Estévez SV, Parikh O, Krabbe LM, Vasudev NS, Doehn C, Marschner N, Waddell T, Ince W, Goebell PJ. PMID: 39565522 [PubMed - as supplied by publisher]
	Successful hormonal and chemical induction of prostate cancer in a rat model: practical guidelines. Vet Res Forum Nascimento-Gonçalves E, L Faustino-Rocha AI, Seixas F, Colaço B, Ferreira R, Oliveira PA. PMID: 39564469 [PubMed]
	The Application of Prostate Specific Membrane Antigen in the Diagnosis and Treatment of Prostate Cancer: Status and Challenge. Onco Targets Ther Zeng T, Xie Y, Chai K, Sang H. PMID: 39564453 [PubMed]
	Optimizing Multiparametric MRI Protocols for Prostate Cancer Detection: A Comprehensive Assessment Aligned with PI-RADS Guidelines. Health Sci Rep Jamshidi MH, Fatemi A, Karami A, Ghanavati S, Dhruba DD, Negarestanian MH. PMID: 39564352 [PubMed]
	Genomic profiling and molecular characterization of non-clear cell renal cell carcinoma: a narrative review from a clinical perspective. Ther Adv Med Oncol Pezzicoli G, Musci V, Ciciriello F, Salonne F, Cafforio P, Lionetti N, Ragno A, Rizzo M. PMID: 39563719 [PubMed]
	The Comparative Study on the Application Value of Transperineal Prostate Combined Biopsy and Transrectal Prostate Systematic Biopsy in Diagnosing Prostate Cancer in Patients with Different PSA Zones. Urol J Wang H, Wang H, Gao W, Xu P, Wang J, Xu H, Pan D, Ma Y, Zhang R, Zhang P, Pang K. PMID: 39563488 [PubMed - as supplied by publisher]
	Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study. Radiat Oncol Miyazawa Y, Nakayama H, Kawamura H, Miyasaka Y, Onishi M, Kaminuma T, Sekine Y, Matsui H, Ohno T, Suzuki K. PMID: 39563371 [PubMed - indexed for MEDLINE]
	Trend in incidence and clinicopathological characteristics of prostate cancer in Northern Tanzania: analysis from a population based cancer registry data 2015-2021. BMC Cancer Ngowi BN, Mremi A, Mbwambo OJ, Seventh F, Kalonge SH, Nkya C, Mshana TJ, Kennedy IJ, Mitao MP, Nyindo M, Mmbaga BT, Mteta KA. PMID: 39563287 [PubMed - indexed for MEDLINE]
	Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging-guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial. Eur Urol Oncol Discacciati A, Abbadi A, Clements MS, Annerstedt M, Carlsson S, Grönberg H, Jäderling F, Eklund M, Nordström T. PMID: 39562218 [PubMed - as supplied by publisher]
	A metagene based similarity network fusion approach for multi-omics data integration identified novel subtypes in renal cell carcinoma. Brief Bioinform Jia C, Wang T, Cui D, Tian Y, Liu G, Xu Z, Luo Y, Fang R, Yu H, Zhang Y, Cui Y, Cao H. PMID: 39562162 [PubMed - indexed for MEDLINE]
	Salvage Stereotactic Radiotherapy for Nodal Oligo-Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin Genitourin Cancer Aman A, Akram A, Akram B, Husnain A, Akram A, Akram S, Ahmad E, Nadeem A. PMID: 39561634 [PubMed - as supplied by publisher]
	UromonitorÂ®: Clinical Validation and Performance Assessment of a Urinary Biomarker within the Surveillance of Non-Muscle Invasive Bladder Cancer Patients. J Urol Ramos P, Brás JP, Dias C, Bessa-Gonçalves M, Botelho F, Silva J, Silva C, Pacheco-Figueiredo L. PMID: 39561374 [PubMed - as supplied by publisher]
	Correction to: Effect ofÂ extending theÂ period fromÂ oral administration ofÂ 5-aminolevulinic acid hydrochloride toÂ photodynamic diagnosis duringÂ transurethral resection forÂ non-muscle invasive bladder cancer onÂ diagnostic accuracy andÂ safety: aÂ single-arm multicenter phase III trial. Int J Clin Oncol Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M. PMID: 39560814 [PubMed - as supplied by publisher]

Articles 1 - 20 / 163335

Page 1 of 8167



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy